GGrantIndex
← Leaderboards

S John Mihic

University Of California San Francisco

$5,253,471
Attributed
$6,558,516
Total exposure
8
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $660.2K · FY200516
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$6,558,516 · 8

By mechanism

R01$3,163,163 · 2
P01$1,892,832 · 2
P50$697,299 · 1
U01$436,743 · 1
R21$225,000 · 1
R03$143,479 · 1

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Glycine Receptors

Research focus

Glycine ReceptorsEthanolXenopus OocyteProtein Structure FunctionGaba ReceptorPhage DisplaySite Directed MutagenesisCellsIn VivoAlcohol EffectBaseAffectNeurotransmitter ReceptorIon ChannelLibrariesCell Surface ProteinsPeptidesBehavioralMediator Of Activation ProteinOverexpressionAlcohol AbuseBinding (Molecular Function)MediatingGenetic Manipulation

Grant awards (33)

A screen for peptides that alter BK channel-mediated alcohol intoxication$459,050
R01 · FY2016 · AA
Identification of Novel Therapeutic Agents for Alcohol Abuse using Phage Display$173,758
P01 · FY2016 · AA · contact PI
A screen for peptides that alter BK channel-mediated alcohol intoxication$445,277
R01 · FY2015 · AA
Identification of Novel Therapeutic Agents for Alcohol Abuse using Phage Display$168,544
P01 · FY2015 · AA · contact PI
A screen for peptides that alter BK channel-mediated alcohol intoxication$46,428
R01 · FY2015 · AA
A screen for peptides that alter BK channel-mediated alcohol intoxication$337,196
R01 · FY2014 · AA
Identification of Novel Therapeutic Agents for Alcohol Abuse using Phage Display$168,545
P01 · FY2014 · AA · contact PI
A screen for peptides that alter BK channel-mediated alcohol intoxication$323,117
R01 · FY2013 · AA
Identification of Novel Therapeutic Agents for Alcohol Abuse using Phage Display$161,281
P01 · FY2013 · AA · contact PI
A screen for peptides that alter BK channel-mediated alcohol intoxication$346,500
R01 · FY2012 · AA
Identification of Novel Therapeutic Agents for Alcohol Abuse using Phage Display$173,196
P01 · FY2012 · AA · contact PI
In vitro screening of novel therapeutic agents for the treatment of alcohol abuse$71,379
R03 · FY2010 · AA · contact PI
In vitro screening of novel therapeutic agents for the treatment of alcohol abuse$72,100
R03 · FY2009 · AA · contact PI
Sites of Ethanol Action on Gaba and Glycerine Receptors$195,563
R01 · FY2008 · AA · contact PI
Sites of Ethanol Action on Gaba and Glycerine Receptors$195,563
R01 · FY2007 · AA · contact PI
Sites of Ethanol Action on Gaba and Glycerine Receptors$201,404
R01 · FY2006 · AA · contact PI
Sites of Ethanol Action on GABA and Glycerine Receptors$206,250
R01 · FY2005 · AA
Anesthetic effects on glycine and GABA-A receptors$112,500
R21 · FY2004 · GM
In vivo consequences of receptor mutations that mimic c*$149,904
U01 · FY2003 · AA
Anesthetic effects on glycine and GABA-A receptors$112,500
R21 · FY2003 · GM
CORE--MUTAGENESIS LABORATORY$305,280
P01 · FY2002 · GM
MOLECULAR STUDIES OF 5HT3 RECEPTOR SENSITIVE TO ETHANOL$178,517
P50 · FY2002 · AA
MOLECULAR STUDIES OF 5HT3 RECEPTOR SENSITIVE TO ETHANOL$178,517
P50 · FY2002 · AA
In vivo consequences of receptor mutations that mimic c*$145,539
U01 · FY2002 · AA
SITES OF ETHANOL ACTION ON GABA AND GLYCINE RECEPTORS$139,631
R01 · FY2002 · AA
CORE--MUTAGENESIS LABORATORY$305,280
P01 · FY2001 · GM
CORE--MUTAGENESIS LABORATORY$305,280
P01 · FY2001 · GM
MOLECULAR STUDIES OF 5HT3 RECEPTOR SENSITIVE TO ETHANOL$178,517
P50 · FY2001 · AA
Receptor mutations mimic ethanol/antagonist exposure$141,300
U01 · FY2001 · AA
SITES OF ETHANOL ACTION ON GABA AND GLYCINE RECEPTORS$135,566
R01 · FY2001 · AA
MOLECULAR STUDIES OF 5HT3 RECEPTOR SENSITIVE TO ETHANOL$161,748
P50 · FY2000 · AA
CORE--MUTAGENESIS LABORATORY$131,668
P01 · FY2000 · GM
SITES OF ETHANOL ACTION ON GABA AND GLYCINE RECEPTORS$131,618
R01 · FY2000 · AA